2023-2024 Grand Jury Report: Narcan - Saving Lives in Riverside County*
⚠️ Translation Notice: This content has been automatically translated. The original English text is the official version. Translation may contain errors.
⚠️ Este contenido ha sido traducido automáticamente. El texto original en inglés es la versión oficial. La traducción puede contener errores.
Findings and Recommendations 3 findings
Additional Recommendations 2
These recommendations are not explicitly linked to specific findings.
-
R15-24-11 25.44 -1.699 88 699
-
R65-7475+ 200 400 0 600 800 1,000 1,200 1.400 1,600 1,800 Suspected Opioid Overdose & Fatality by Gender (2023) Suspected Opioid Overdose & Fatality by Gender Suspected Overdose Fatality 2.269 Male 107 Incident Patient Disposition in Suspected Opioid OD (2023) Incident Patient Disposition in Suspected Opioid OD Treated; Transport... Treated; Released (... In order to get an in depth look at oploid overdose data, it is important to understand the Dead at Scene Refused Treatment... Refused Treatment; Transported willingness of patients that are seen and treated by EMS providers to comply with provider recommendations. This provides context and highlights potential obstacles in overdose treatments. 5.6% The following data represents patients that go against medical advice (AMA), thereby refuse 6.7% treatment, or transport to a designated healthcare facility for further treatment. Patients encountered that were determined to be deceased when EMS units arrived are denoted as Dead at Scene. Treated; Transported Treated; Released (AMA) 2,530 197 Refused Treatment; No Transport Dead at Scene 62 166 85.6% Naloxone/Narcan Administration & Efficacy (2023) Administered by Prior to Arrival ΑZ Narcan Administered by EMS 2,104 600 400 452 Narcan Administered Prior to Arrival 200 53 22 15 8 167 1,060 0 Ow Enforcement Bystander Stoff Law Enforcement & Staff Friend Healthcare Provider Bustonder & Law Erfortement Formily & Law Enforcement Healthcare Provider & Low En. Friend & Low Enforcement Bystonder & Staff Fornily No Narcan Administered Patient Response to Naloxone/Narcan Administration (2023) Patient Response to Narcan Administration Improved Unchanged Unchanged Improved 100% 10.8% 14 25 32 24 29 39 20 25 16 26 27 157 164 245 255 247 221 191 202 225 237 204 203 80% 60% 40% 20% 0% 780 569 Wat 801 Wat 7013 5013 5013 5013 5013 5013 5013 5013 5 89.2% Leave Behind Naloxone Program (2023) Leave Behind Naloxone Program Several Ambulance/Fire Agencies within Riverside County provide naloxone kits to patients/family/at-risk persons Participating Provider Agencies AMR Cathedral City Fire Department Corona Fire Department Soboba Fire Department Total Count Date Range Count REMSA Policy 3309 - Intranasal Naloxone Use by Public Safety Personnel Intranasal Naloxone Use by Public Safety 3309 RIVERSIDE COUNTY Personnel Operational Policy Last Revised: December 1, 2023 Last Reviewed: October 4, 2022 PURPOSE To establish the processes and procedures to allow for approved public safety personnel (PSP) to provide intranasal naloxone to patients with suspected acute narcotic overdose. Training Standards 1. Agencies that employ PSPs in Riverside County seeking to utilize naloxone to manage patients with suspected narcotic overdose shall be authorized and approved by REMSA in accordance with state laws, regulations and REMSA policies. Authorized agencies shall administer naloxone in accordance with this policy. 2. PSPs must be trained to the Public Safety Personnel First Aid and CPR standard as outlined in Title 22, Division 9, Chapter 1.5, Section 100017 (found here: https://govt.westlaw.com/calregs/Document/I64A10E20B55D11E4BD3CC9706BA5168A?viewType=FullText&origi nationContext=documenttoc&transitionType=CategoryPageItem&contextData=(sc.Default)&bhcp=1) and maintain ongoing competencies and proficiencies as outlined by Section 100022 (found here: https://govt.westlaw.com/calregs/Document/l654EB340B55D11E4BD3CC9706BA5168A?viewType=FullText&origi nationContext=documenttoc&transitionType=CategoryPageItem&contextData=(sc.Default). 3. Ongoing competency for the administration of intranasal naloxone must be maintained every two (2) years, training for ongoing competency must be approved by REMSA. Each authorized agency that employs PSPs that is requesting authorization will submit:
Agency Responses 16
Government agencies' official responses to this report's findings and recommendations. Click on a response to see the structured breakdown.
No Responses Found 5
Government entities assigned to respond to this report. No response documents have been linked in our database.
* This report's PDF did not contain easily extractable text and required Optical Character Recognition (OCR) for analysis. There may be minor errors in the extracted findings and recommendations due to OCR limitations with scanned documents.